First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer

Clinical trial NCT06934538 · RECRUITING

Trial details

NCT number: NCT06934538
Sponsor: Brenus Pharma
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Unresectable Metastatic Colorectal Cancer Unresectable Locally Advanced Colorectal Cancer

Start date: 2025-06-17
Primary completion: 2028-06-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.